Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock, returning 9,233.8%.

ASSET	% RETURN
Regencell Bioscience (RGC)	9,233.83%
CannBioRx Life Sciences (ATNFW)	4,287.76%
WW International, Inc Common Stock (WW)	2,495.42%
DeFi Development (DFDV)	2,213.87%
HCM II Acquisition (HONDW)	2,055.17%
Blue Gold Limited Warrant (BGLWW)	1,837.5%
Triumph (TGI)	1,462.98%
Oncology Institute (TOIIW)	1,450%
Zepp Health (ZEPP)	1,406.92%
Diginex Limited Ordinary Shares (DGNX)	1,214.55%
Oncology Institute (TOI)	1,148.37%
CEA Industries (BNCWW)	1,142.28%
K Wave Media (KWMWW)	1,113.59%
CEA Industries (VAPEW)	1,108.05%
Cohen Circle Acquisition Corp I Warrant (CCIRW)	1,036.87%
Newegg Commerce (NEGG)	1,017.5%
Webull Corporation Warrants (BULLW)	924.58%
Anbio Biotechnology Class A Ordinary Shares (NNNN)	890.49%
USA Rare Earth (USARW)	888%
Ainos (AIMDW)	873.63%
Rich Sparkle Holdings Limited Ordinary Shares (ANPA)	868.61%
Abivax SA American Depositary Shares (ABVX)	852.49%
Global Interactive Technologies (GITS)	833.61%
SRM Entertainment, Inc Common Stock (SRM)	810.55%
Kindly MD, Inc Common Stock (KDLY)	779.03%